Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01101425 · ClinicalTrials.gov registry record
Male Breast Cancer: Understanding the Biology for Improved Patient Care
A clinical trial, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- Active
- Registry status
- 200
- Enrollment target
NCT01101425: Active study, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
NCT01101425 is a clinical trial that is active but no longer recruiting, run by European Organisation for Research and Treatment of Cancer - EORTC. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01101425 is active but no longer recruiting, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
Rationale: Gathering medical information and tumor samples from patients with male breast cancer may help doctors learn more about the disease. Purpose retrospective part: to perform a large international retrospective analysis of clinical and biological data of male BC patients treated in the participating centers from 1990 to 2010. Purpose prospective part: to create a registry of men with breast cancer for a period of 30 months (starting early 2014).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2010-12 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT01101425 still lists
NCT01101425 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01101425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01101425 about?
NCT01101425 is a clinical study titled "Male Breast Cancer: Understanding the Biology for Improved Patient Care". Rationale: Gathering medical information and tumor samples from patients with male breast cancer may help doctors learn more about the disease. Purpose retrospective part: to perform a large international retrospective analysis of clinical and biological data of male BC patients treated in the part...
What is the current status of trial NCT01101425?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2010-12. Estimated completion is 2026-12-31.
Who is sponsoring clinical trial NCT01101425?
This trial is sponsored by European Organisation for Research and Treatment of Cancer - EORTC, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia